Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA Fluorescence-Guided Detection of Malignant Gliomas
NCT00752323Phase 2Completed
- Start
- Dec 2009
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of 5-aminolevulinic acid in malignant glioma and glioblastoma multiforme (GBM). Started Dec 2009; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
malignant gliomaglioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00752323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752323.